Probiotic Gene Expression for Continuous Acetaldehyde Detoxification

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing methods to alleviate alcohol hangover symptoms, particularly those targeting acetaldehyde toxicity, either affect blood alcohol content or exacerbate symptoms, and direct oral cavity approaches are ineffective against systemic toxicity.

Innovation Solution

Genetically engineered probiotic microorganisms, such as Bacillus subtilis, are designed to constitutively express acetaldehyde dehydrogenase enzymes by modifying the flagellin gene promoter to reduce CsrA repression and deleting the flgM gene, ensuring high and continuous enzyme production to metabolize acetaldehyde internally.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If ethanol metabolism is accelerated to remove alcohol faster, then blood alcohol content is reduced, but acetaldehyde exposure increases and hangover symptoms worsen

Engineering Contradiction:

Improveethanol metabolism rateVSAvoidacetaldehyde toxicity

Core Design Contradiction:

SpeedVSObject-affected harmful factors

Solution Approach 1:

The patent introduces probiotic microorganisms as intermediary agents that directly metabolize acetaldehyde in the gastrointestinal tract. These microorganisms express acetaldehyde dehydrogenase enzyme to convert acetaldehyde to acetate, acting as a mediator between acetaldehyde production and elimination, thereby preventing acetaldehyde from entering the bloodstream while not interfering with ethanol metabolism rate

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent extracts and targets the specific harmful intermediate (acetaldehyde) from the ethanol metabolism pathway by using probiotic microorganisms to selectively metabolize acetaldehyde in the gastrointestinal tract, separating the removal of the toxic intermediate from the overall ethanol metabolism process

Inventive Principle:

Principle #2Taking out (Extraction)

2Use of energy by moving object

If acetaldehyde dehydrogenase is expressed only under specific conditions, then resource consumption is reduced, but acetaldehyde detoxification is not continuous

Engineering Contradiction:

Improveenergy consumption for enzyme expressionVSAvoidduration of acetaldehyde detoxification

Core Design Contradiction:

Use of energy by moving objectVSDuration of action of stationary object

Solution Approach 1:

The patent employs dynamic promoter systems that respond to physiological conditions such as oxygen availability, carbon source, or quorum sensing signals to regulate acetaldehyde dehydrogenase expression. This allows the enzyme to be expressed at high levels only when needed (e.g., during anaerobic conditions when acetaldehyde accumulates), optimizing the balance between energy consumption and detoxification duration

Inventive Principle:

Principle #15Dynamics

Solution Approach 2:

The patent utilizes changes in environmental parameters (oxygen tension, pH, nutrient availability) to trigger differential expression of acetaldehyde dehydrogenase. By linking enzyme expression to physiological state parameters, the system ensures detoxification capacity is activated when acetaldehyde load is highest while minimizing unnecessary energy expenditure during low-risk conditions

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered microorganisms effectively reduce acetaldehyde levels in the body, mitigating hangover symptoms without affecting blood alcohol content, providing a direct and efficient means of detoxification.

Implementation Method 1

a flagellin gene promoter operatively linked with a heterologous nucleotide sequence encoding a subject polypeptide

Methodology Applied

Scientific EffectTranscription:

Implementation Method 2

the flagellin gene promoter comprises one or more genetic modifications that reduce CsrA repression of translation of an mRNA transcribed from the flagellin gene promoter

Methodology Applied

Scientific EffectTranslation repression:

Implementation Method 3

a genetic modification of a flgM gene that reduces inhibition of SigD initiation of transcription

Methodology Applied

Scientific EffectTranscriptional inhibition:

Implementation Method 4

the subject polypeptide is an aldehyde dehydrogenase... catalyze oxidation of acetaldehyde

Methodology Applied

Scientific EffectOxidation: Oxidation

Data Source

PatentUS12539317B2Gene expression system for probiotic microorganisms

Publication Date: 2026.02.03 ZBIOTICS CO

AI summary

Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.